Implementation of a targeted metabolomics platform using LC-MS/MS for expanded newborn screening, detecting 58 metabolic disorders with a false-positive rate below 0.01% in 120,000 neonatal dried blood spots.
Keywords: Metabolomics, Mass Spectrometry, Newborn Screening, Inborn Errors of Metabolism, LC-MS/MS